Skip to main content

Advertisement

Log in

Pericardioscopy and epi- and pericardial biopsy—a new window to the heart improving etiological diagnoses and permitting targeted intrapericardial therapy

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

The etiology of pericardial effusions remains unresolved in many cases because not the full spectrum of diagnostic methods including cytology, histology, immunohistology and PCR on cardiotropic agents, which are currently available, used in many institutions. After comprehensive clinical workup and use of imaging methods, such as echocardiography and cardiac MRI, pericardiocentesis and epicardial and pericardial biopsy were carried out under pericardioscopical control of the biopsy site. Biopsies and fluid were evaluated by cytological, histological, immunological and molecular (PCR) methods in 259 patients of our tertiary referral center following an identical clinical pathway, diagnostic and therapeutic algorithm in all cases. A standard clinical pathway and the same diagnostic and therapeutic algorithms were used in all cases. When all methods are applied to patients with pericardial effusions, “idiopathic” pericardial effusion is no longer a relevant diagnosis. Autoreactive and lymphocytic pericardial effusions are the leading diagnosis in 35 % of patients in the prospective Marburg registry, followed by malignant effusions in 28 % of cases. Viral genome was assessed in fluid and epi- as well as pericardial biopsies in 12 %, followed by post-traumatic/iatrogenic effusions in 15 % and purulent/bacterial effusions in only 2 %. Pericardioscopy permits the macroscopic inspection of the pulsating heart and its disease-associated macroscopic alterations. It also permits safe and targeted biopsy for further investigations of the tissue. Therapy, tailored to the individual etiology, can be selected such as intrapericardial instillation in autoreactive effusions with triamcinolone and with cisplatin or thiotepa in neoplastic effusions. With this approach the recurrence of pericardial effusion can be avoided effectively. A comprehensive approach to the diagnosis of pericardial effusions in conjunction with pericardioscopy for targeted tissue sampling is the prerequisite for an etiologically based intrapericardial and systemic treatment, which improves outcome and prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Maisch B, Ristic AD, Seferovic M, Tsang SMT (2011) Interventional pericardiology. Pericardiocentesis, pericardioscopy, pericardial biopsy balloon pericardiotomy and intrapericardial therapy. Springer, Heidelberg

    Book  Google Scholar 

  2. Volkmann J (1957) Perikardioskopie und Kontrastdarstellung des Herzbeutels mit anatomischen Grundlagen [Pericardioscopy and contrast imaging of the pericardium including essentials of its anatomy]. Z Aerztliche Fortb 24:1105–1108

    Google Scholar 

  3. Sinitsyn NP (1958) Method of implantation of the cannula into the thorax for visual observation of coronary circulation [in Russian]. Biull Eksp Biol Med 39(3):74–76

    Google Scholar 

  4. Santos GH, Frater RWM (1977) The subxiphoid approach in the treatment of pericardial effusion. Ann Thorac Surg 23:467–470

    Article  PubMed  CAS  Google Scholar 

  5. Kondos G, Rich S, Levitsky S (1986) Flexible fiberoptic pericardioscopy for the diagnosis of pericardial disease. J Am Coll Cardiol 7:432–434

    Article  PubMed  CAS  Google Scholar 

  6. Kondos G, Rich S, Levitsky S (1986) Flexible fiberoptic pericardioscopy. Chest 90(5):787–788

    Article  PubMed  CAS  Google Scholar 

  7. Little AG, Ferguson MK (1986) Pericardioscopy as adjunct to pericardial window. Chest 89(1):53–55

    Article  PubMed  CAS  Google Scholar 

  8. Millaire A, Wurtz A, Brullard B et al (1988) Value of pericardioscopy in pericardial effusion. Arch Mal Coeur 81:1071–1076

    PubMed  CAS  Google Scholar 

  9. Millaire A, Wurtz A, de Groote P, Saudemont A, Chambon A, Ducloux G (1992) Malignant pericardial effusions: usefulness of pericardioscopy. Am Heart J 124(4):1030–1034

    Article  PubMed  CAS  Google Scholar 

  10. Wurtz A, Chambon JP, Millaire A, Saudemont A, Ducloux G (1992) Pericardioscopy: techniques, indications and results. Apropos of an experience with 70 cases. Ann Chir 46(2):188–193

    PubMed  CAS  Google Scholar 

  11. Nugue O, Millaire A, Porte H et al (1996) Pericardioscopy in the etiologic diagnosis of pericardial effusion in 141 consecutive patients. Circulation 94(7):1635–1641

    Article  PubMed  CAS  Google Scholar 

  12. Porte HL, Janecki-Delebecq TJ, Finzi L, Metois DG, Millaire A, Wurtz AJ (1999) Pericardioscopy for primary management of pericardial effusion in cancer patients. Eur J Cardiothorac Surg 16(3):287–291

    Article  PubMed  CAS  Google Scholar 

  13. Seferovic PM, Ristic AD, Maksimovic R, Tatic V, Ostojic M, Kanjuh V (2003) Diagnostic value of pericardial biopsy: improvement with extensive sampling enabled by pericardioscopy. Circulation 107:978–983

    Article  PubMed  Google Scholar 

  14. Maisch B, Drude L (1991) Pericardioscopy—a new diagnostic tool in inflammatory diseases of the pericardium. Eur Heart J 12(Suppl. D):2–6

    Article  PubMed  Google Scholar 

  15. Maisch B, Drude L (1992) Pericardioscopy—a new window to the heart in inflammatory cardiac diseases. Herz 17:71–78

    PubMed  CAS  Google Scholar 

  16. Maisch B, Bethge C, Drude L, Hufnagel G, Herzum M, Schönian U (1994) Pericardioscopy and epicardial biopsy—new diagnostic tools in pericardial and perimyocardial disease. Eur Heart J 15(suppl. C):68–73

    Article  PubMed  Google Scholar 

  17. Maisch B, Karatolius K (2008) New possibilities of diagnostics and therapy of pericarditis. Internist (Berl) 49(1):17–26

    Article  CAS  Google Scholar 

  18. Maisch B, Ristic AD, Rupp H, Spodick DH (2001) Pericardial access using the PerDUCER and flexible percutaneous pericardioscopy. Am J Cardiol 88(11):1323–1326

    Article  PubMed  CAS  Google Scholar 

  19. Rupp H, Rupp O, Alter P, Jung N, Pankuweit S, Maisch B (2010) Regeneration by stem cells. Need for minimal invasive access(AttachLifter) the normal pericardial cavity. Herz 7:458–466

    Article  Google Scholar 

  20. Nataf P, Cacoub P, Regan M et al (1998) Video-thoracoscopic pericardial window in the diagnosis and treatment of pericardial effusions. Am J Cardiol 82:125–126

    Article  Google Scholar 

  21. Robles R, Pinero A, Lujan JA et al (1997) Thoracoscopic partial pericardiectomy in the diagnosis and management of pericardial effusion. Surg Endosc 11:253–256

    Article  PubMed  CAS  Google Scholar 

  22. Geissbühler K, Leiser A, Fuhrer J, Ris HB (1998) Video-assisted thoracoscopic pericardial fenestration for loculated or recurrent effusions. Eur J Cardiothorac Surg 14:403–408

    Article  PubMed  Google Scholar 

  23. Ohno K, Utsumi T, Sasaki Y, Suzuki Y (2005) Videopericardioscopy using endothoracic sonography for lung cancer staging. Ann Thorac Surg 79(5):1780–1782

    Article  PubMed  Google Scholar 

  24. Karthik S, Milton R, Papagiannopoulos K (2005) Simultaneous double video mediastinoscopy and video mediastinotomy–a step forward. Eur J Cardiothorac Surg 27(5):920–922

    Article  PubMed  Google Scholar 

  25. Georghiou GP, Stamler A, Sharoni E et al (2005) Video-assisted thoracoscopic pericardial window for diagnosis and management of pericardial effusions. Ann Thorac Surg 80:607–610

    Article  PubMed  Google Scholar 

  26. Pego-Fernandes PM, Mariani AW, Fernandez F, Ianni BM, Stolf NG, Jatene FB (2008) The role of videopericardioscopy in evaluating indeterminate pericardial effusions. Heart Surg Forum 11(1):E62–E65

    Article  PubMed  Google Scholar 

  27. Maisch B, Seferović PM, Ristić AD et al (2004) Task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology. European Society of Cardiology Guidelines: diagnosis and management of the pericardial diseases. Executive summary. Eur Heart 25(7):587–610

    Article  Google Scholar 

  28. Maisch B, Pankuweit S (2012) Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy. Herz 37:644–656

    Article  PubMed  CAS  Google Scholar 

  29. Maisch B, Pankuweit S, Brilla C et al (1999) Intrapericardial treatment of inflammatory and neoplastic pericarditis guided by pericardioscopy and epicardial biopsy—results from a pilot study. Clin Cardiol 22(suppl 1):17–22

    Article  Google Scholar 

  30. Maisch B, Ristic AD, Pankuweit S (2002) Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone: the way to avoid side effects of systemic corticosteroid therapy. Eur Heart J 23:1503–1508

    Article  PubMed  CAS  Google Scholar 

  31. Maisch B, Ristic AD, Pankuweit S, Neubauer A, Moll R (2002) Neoplastic pericardial effusion: efficacy and safety of intrapericardial treatment with cisplatin. Eur Heart J 23:1625–1631

    Article  PubMed  CAS  Google Scholar 

  32. Maisch B, Ristic A, Pankuweit S (2010) Evaluation and management of pericardial effusion in patients with neoplastic disease. Prog Cardiovasc Dis 53(2):157–163

    Article  PubMed  Google Scholar 

  33. Spodick DH (1997) Diagnostic interpretation of pericardial fluids. Chest 111:1156–1157

    Article  PubMed  CAS  Google Scholar 

  34. Kjeldsberg CR, Knight JA (eds) (1993) Body fluids, 3rd edn. American Society of Clinical Pathologists Press, Chicago, pp 159–254

    Google Scholar 

  35. Meyers DG, Meyers RE, Prendergast TW (1997) The usefulness of diagnostic test on pericardial fluid. Chest 111:1213–1221

    Article  PubMed  CAS  Google Scholar 

  36. Reyes CV, Strinden C, Banerji M (1981) The role of cytology in neoplastic tamponade. Acta Cytol 26:299–302

    Google Scholar 

  37. Theologides A (1978) Neoplastic cardiac tamponade. Semin Oncol 5:181–192

    PubMed  CAS  Google Scholar 

  38. Posner WR, Cohen GI, Skarin AT (1981) Pericardial disease in patients with cancer: the differential diagnosis of malignant from idiopathic and radiation-induced pericarditis. Am J Med 71:407–413

    Article  PubMed  CAS  Google Scholar 

  39. Meyers DG, Boyska DJ (1989) Diagnostic usefulness of pericardial fluid cytology. Chest 95:1142–1143

    Article  PubMed  CAS  Google Scholar 

  40. Krikorian JG, Hancock EW (1978) Pericardiocentesis. Am J Med 65:808–814

    Article  PubMed  CAS  Google Scholar 

  41. Corey GR, Campbell PT, Van Trigt P et al (1993) Etiology of large pericardial effusions. Am J Med 95:209–213

    Article  PubMed  CAS  Google Scholar 

  42. Thadani U, Iveson JM, Wright V (1975) Cardiac tamponade, constrictive pericarditis and pericardial resection in rheumatic arthritis. Medicine (Baltimore) 54:261–270

    Article  CAS  Google Scholar 

  43. Leventhal LJ, De Marco DM, Zurier RB (1990) Antinuclear antibodies in pericardial fluid from a patient with primary cardiac lymphoma. Arch Intern Med 150:113–114

    Article  Google Scholar 

  44. Maisch B, Trostel-Soeder R, Stechemesser E et al (1982) Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. Clin Exp Immunol 48:533–545

    PubMed  CAS  Google Scholar 

  45. Maisch B (1987) The sarcolemma as antigen in the secondary immunopathogenesis of myopericarditis. Eur Heart J 8(suppl J):155–165

    Article  Google Scholar 

  46. Maisch B, Bauer E, Cirsi M et al (1993) Cytolytic crossreactive antibodies directed against the cardiac membrane and viral proteins in coxsackievirus B3 and B4 myocarditis. Characterization and pathogenetic relevance. Circulation 87(suppl 5):IV49–IV65

    PubMed  CAS  Google Scholar 

  47. Maisch B, Noutsias M, Ruppert V, Richter A, Pankuweit S (2012) Cardiomyopathies: classification, diagnosis, and treatment. Heart Fail Clin 8:53–78

    Article  PubMed  Google Scholar 

  48. Cooper LT, Baughman KL, Feldman AM et al (2007) The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 116:2216–2233

    Article  PubMed  Google Scholar 

  49. Maisch B, Outzen H, Roth D et al (1991) Prognostic determinants in conventionally treated myocarditis and perimyocarditis—focus on antimyolemmal antibodies. Eur Heart J 12(Suppl B):81–87

    Article  PubMed  Google Scholar 

  50. Maisch B, Richter A, Koelsch S et al (2006) Management of patients with suspected (peri-)myocarditis and inflammatory dilated cardiomyopathy. Herz 31:881–890

    Article  PubMed  Google Scholar 

  51. Tomkowski W, Szturmowicz M, Fijalkowska A, Burkowski J, Filipecki S (1997) New approaches to the management and treatment of malignant pericardial effusion. Support Care Cancer 5(1):64–66

    Article  PubMed  CAS  Google Scholar 

  52. Tondini M, Rocco G, Bianchi C, Severi C, Corbellini D (1995) Intracavitary cisplatin (CDDO) in the treatment of metastatic pericardial involvement from breast and lung cancer. Monaldi Arch Chest Dis 50(2):86–88

    PubMed  CAS  Google Scholar 

  53. Colleoni M, Martinelli G, Beretta F et al (1998) Intracavitary chemotherapy with thiotepa in malignant pericardial effusions: an active and well-tolerated regimen. J Clin Oncol 16:2371–23716

    PubMed  CAS  Google Scholar 

  54. Girardi LN, Ginsberg RJ, Burt ME (1997) Pericardiocentesis and intrapericardial sclerosis: effective therapy for malignant pericardial effusions. Ann Thorac Surg 64(5):1422–1427

    Article  PubMed  CAS  Google Scholar 

  55. Martioni A, Cipolla CM, Cardinale D, Civelli M, Lamantia G, Colleoni M, Fiorentini C (2004) Long-term results of intrapericardial chemotherapeutic treatment of malignant pericardial effusions with thiotepa. Chest 126(5):1412–1416

    Article  Google Scholar 

  56. Peraino RA (1983) Pericardial effusion in patients treated with maintenance dialysis. Am J Nephrol 3(6):319–322

    Article  PubMed  CAS  Google Scholar 

  57. Fuller TJ, Knochel JP, Brennan JP, Fetner CD, White MG (1976) Reversal of intractable uremic pericarditis by triamcinolone hexacetonide. Arch Intern Med 136(9):979–982

    Article  PubMed  CAS  Google Scholar 

  58. Buselmeier TJ, Davin TD, Simmons RL, Najarian JS, Kjellstrand CM (1978) Treatment of intractable uremic pericardial effusion. Avoidance of pericardiectomy with local steroid instillation. JAMA 240(13):1358–1359

    Article  PubMed  CAS  Google Scholar 

  59. Jr Quigg RJ, Idelson BA, Yoburn DC, Hymes JL, Schick EC, Bernard DB (1985) Local steroids in dialysis-associated pericardial effusion. A single intrapericardial administration of triamcinolone. Arch Intern Med 145(12):2249–2250

    Article  PubMed  Google Scholar 

  60. Defouilloy C, Meyer G, Starna M et al (1997) Intrapericardial fibrinolysis: a useful treatment in the management of purulent pericarditis. Intensive Care Med 23(1):5–10

    Article  Google Scholar 

  61. Ustunsoy H, Celkan MA, Sivrikoz MC et al (2002) Intrapericardial fibrinolytic therapy in purulent pericarditis. Eur J Cardio-thorac Surg 22(3):373–376

    Article  Google Scholar 

  62. Schafer M, Lepoir M, Delabays A, Ruchat P, Schaller MD, Borccard AF (2002) Intrapericardial urokinase irrigation and systemic corticosteroids: an alternative to pericardectomy for persistent fibrino-purulent pericarditis. Cardiovasc Surg 10(5):508–511

    Article  PubMed  CAS  Google Scholar 

  63. Ekim H, Demirbag R (2004) Intrapericardial streptokinase for purulent pericarditis. Surg Today 34:569–572

    Article  PubMed  CAS  Google Scholar 

  64. Tomkowski WZ, Gralec R, Kuca P, Burokowsi J, Orlowski T, Kurzyna M (2004) Effectiveness of intrapericardial administration of streptokinase in purulent pericarditis. Herz 29(8):802–805

    Article  PubMed  Google Scholar 

  65. Cui Hb, Chen XY, Cui CC et al (2005) Prevention of pericardial constriction by transcatheter intrapericardial fibrinolysis with urokinase. Chin Med Sci 20(1):5–10

    Google Scholar 

  66. Sosa E, Scanavacc M, d’Avila A (1996) A new technique to perform epicardial mapping in the electrophysiology laboratory. J Cardiovasc Electrophysiol 7(6):531–536

    Article  PubMed  CAS  Google Scholar 

  67. Sosa E, Scanavacca M, d’Avila A (1999) Different ways of approaching the normal pericardial space. Circulation 100(24):e115–e116

    Article  PubMed  CAS  Google Scholar 

  68. Maisch B, Ristic AD, Rupp H, Spodick DH (2001) Pericardial access using the PerDUCER and flexible percutaneous pericardioscopy. Am J Cardiol 88:1323–1326

    Article  PubMed  CAS  Google Scholar 

  69. Rupp H, Rupp TP, Alter P, Jung N, Pankuweit S, Maisch B (2010) Intrapericardial procedures for cardiac regeneration by stem cells. Herz 35:458–466

    Article  PubMed  CAS  Google Scholar 

  70. Patronik NA, Riviere CN, El Qarra S, Zenati MA(2005). The Heart-Lander: a novel epicardial crawling robot for myocardial injection. Proceedings of the 19th International Congress of Computer Assisted Radiology and Surgery, Elsevier1291C: 735–739

  71. Ota T, Patronik NA, Schwarzman D, Riviere CN, Zenat MI (2008) Minimally invasive epicardial injections using a novel semiautonomous robotic device. Circulation 118(14 Suppl):115–120

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bernhard Maisch.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maisch, B., Rupp, H., Ristic, A. et al. Pericardioscopy and epi- and pericardial biopsy—a new window to the heart improving etiological diagnoses and permitting targeted intrapericardial therapy. Heart Fail Rev 18, 317–328 (2013). https://doi.org/10.1007/s10741-013-9382-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10741-013-9382-y

Keywords

Navigation